Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
+9,551
New +$1.13M 0.04% 288
2025
Q4
Sell
-19,095
Closed -$1.62M 1587
2025
Q3
$1.62M Buy
+19,095
New +$1.17M 0.09% 211

Other funds holding ABVX

Virtu Financial's ABVX Position: Q1 2026 in Review

Virtu Financial opened a new position in Abivax (ABVX) in Q1 2026: 9,551 shares worth $1.06M. The stake represents 0.04% of the portfolio and ranks #288 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ABVX as recently as Q3 2025.

Virtu Financial first reported a position in ABVX in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.62M in Q3 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Virtu Financial held 9,551 shares of Abivax worth $1.06M as of Q1 2026.
  • Abivax was a new Virtu Financial position in Q1 2026.
  • Abivax made up 0.04% of Virtu Financial's portfolio in Q1 2026, its #288 holding.
  • Virtu Financial first reported a position in Abivax in Q3 2025 and has held it in 2 quarters since.
  • Virtu Financial's Abivax position peaked at $1.62M in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.